510(k) device
ELRA Electrode (7-2B11S
Starmed Co., Ltd. · Unit, Electrosurgical, Endoscopic (With Or Without Accessories) (KNS, Class II) · First FDA decision Apr 11, 2019, newest Oct 25, 2023Enlarged prostate (BPH)Pancreatic and bile duct disease
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
510(k) pathway
Device trials
4
Naming "ELRA"
MAUDE reports
0
Brand "ELRA", since 2015
PubMed studies
74
Mentioning "ELRA"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing ELRA Electrode (7-2B11S
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
K233113 · Decided Oct 25, 2023 · 28 days after receipt
Device type: Unit, Electrosurgical, Endoscopic (With Or Without Accessories) (KNS) · GI, Urology & Nephrology
- ELRA Electrode510(k)
K181758 · Decided Apr 11, 2019 · 283 days after receipt
Device type: Unit, Electrosurgical, Endoscopic (With Or Without Accessories) (KNS) · GI, Urology & Nephrology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "ELRA", any status and sponsor, newest update first.
- Repeated Endobiliary Radiofrequency Ablation Plus Durvalumab, Gemcitabine, and Cisplatin for Unresectable Extrahepatic CholangiocarcinomaPivotal-lookingRecruiting
Aichi Medical UniversityAcademic, hospital or other
NCT07235007 · 120 participants (planned) · Start Nov 20, 2025 · Primary completion Dec 31, 2027
Device: Endobiliary Radiofrequency Ablation (EB-RFA); Plastic Biliary Stent · For: Extrahepatic Cholangiocarcinoma
Sites: Aichi, Japan; Gifu, Japan; Busan, South Korea · 8 sites in all
University Hospitals Dorset NHS Foundation TrustGovernment (non-federal)
NCT04941924 · 24 participants (planned) · Start Sep 16, 2022 · Primary completion Oct 2023
Device: Biliary Stent Placement · For: Malignant Biliary Obstruction
Sites: Bournemouth, United Kingdom; Manchester, United Kingdom
Department of Medical Services Ministry of Public Health of ThailandGovernment (non-federal)
NCT04611100 · 70 participants · Start Apr 1, 2020 · Primary completion Dec 30, 2021
Device: ELRA endoluminal radiofrequency ablation electrode (Taewoong, Seoul, Korea) · For: Hilar Cholangiocarcinoma; Biliary Obstruction
Sites: Bangkok, Thailand
Yonsei UniversityAcademic, hospital or other
NCT02646514 · 48 participants (planned) · Start Sep 2015 · Primary completion Sep 2019
Device: Radiofrequency ablation with stenting; stenting · For: Cholangiocarcinoma, Gallbladder Cancer, Pancreatic Cancer
Sites: Seoul, South Korea
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "ELRA", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code KNS
10,605 reports: 7,586 malfunction, 2,954 injury, 60 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "ELRA"[tiab]. The summary above synthesizes these.
- Ex-vivo Liver Resection and Autotransplantation for Liver Malignancy : A Large Volume Retrospective Clinical Study.
Aini A, Lu Q, Chen Z, et al. · Ann Surg · 2024Research Support, Non-U.S. Gov't
- The Enterococcus faecalis virulence factor ElrA interacts with the human Four-and-a-Half LIM Domains Protein 2.
Jamet A, Dervyn R, Lapaque N, et al. · Sci Rep · 2017Research Support, Non-U.S. Gov't
- Evaluating the Benefits and Risks of Ex Vivo Liver Resection and Autotransplantation in Treating Hepatic End-stage Alveolar Echinococcosis.
Qiu Y, Huang B, Yang X, et al. · Clin Infect Dis · 2022Research Support, Non-U.S. Gov't
- The effect of percutaneous endobiliary radiofrequency ablation on biliary stent patency.
Arik E, Altintas FY, Taydas O, et al. · Sci Prog · 2025
- Therapeutic Targeting of Epithelial-Mesenchymal Cellular Plasticity in Pancreatic Cancer.
Lin EW, Pathak P, O'Shea A, et al. · Clin Cancer Res · 2026
- Xenopus ElrB, but not ElrA, binds RNA as an oligomer: possible role of the linker.
Devaux A, Colegrove-Otero LJ, Standart N · FEBS Lett · 2006Research Support, Non-U.S. Gov't
- Application of ex vivo liver resection and autotransplantation in treating Budd-Chiari syndrome secondary to end-stage hepatic alveolar echinococcosis: A case series.
Wang C, Qiu Y, Wang W · Medicine (Baltimore) · 2021
- Approaches to reconstruction of inferior vena cava by ex vivo liver resection and autotransplantation in 114 patients with hepatic alveolar echinococcosis.
Maimaitinijiati Y, AJi T, Jiang TM, et al. · World J Gastroenterol · 2022
- Enterococcal leucine-rich repeat-containing protein involved in virulence and host inflammatory response.
Brinster S, Posteraro B, Bierne H, et al. · Infect Immun · 2007Research Support, Non-U.S. Gov't
- From liver surgery to liver transplant surgery: new developments in autotransplantation.
Lu Q, Aini A, Tang R, et al. · Curr Opin Organ Transplant · 2022Review, Research Support, Non-U.S. Gov't
- Liver autotransplantation and atrial reconstruction on a patient with multiorgan alveolar echinococcosis: a case report.
Ruze R, Jiang T, Zhang W, et al. · BMC Infect Dis · 2024Case Reports
- Identification of key factors and explainability analysis for surgical decision-making in hepatic alveolar echinococcosis assisted by machine learning.
Zhu DL, Tulahong A, Liu C, et al. · World J Gastroenterol · 2025
Other devices of this type
Also filed under product code KNS.
- Single Use Electrosurgical Knife (KD-612L, KD-612U)Olympus Medical Systems Corporation · 510(k) 2025
- Aqua Medical RF Vapor Ablation SystemAqua Medical, Inc. · 510(k) 2025
- Rezum SystemNxthera, Inc. · 510(k) 2018
- Rezum SystemBoston Scientific · 510(k) 2026
- Single Use Preloaded Sphincterotome V (Distal Wire Guided) (KD-VC600 Series)Olympus Medical Systems Corp. · 510(k) 2025
- Teslatome Bipolar SphincterotomeWilson-Cook Medical, Inc. · 510(k) 2025
- SphincterotomeHangzhou AGS MedTech Co., Ltd. · 510(k) 2023
- Rezum SystemNxthera (A Boston Scientific Company) · 510(k) 2019
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.